Dulaglutide
Metabolic & Weight ManagementLong-acting GLP-1 receptor agonist for type 2 diabetes and weight management, marketed as Trulicity.
Key Benefits
- ✓Improved blood sugar control
- ✓Moderate weight loss (3-5 kg)
- ✓Cardiovascular risk reduction
- ✓Once-weekly convenience
- ✓Reduced appetite
- ✓Lower HbA1c
Dosing Information
Detailed Protocol
Administered via subcutaneous injection once weekly using a pre-filled pen. Can be taken any day of the week, with or without food. Dose escalation over 8-12 weeks.
About Dulaglutide
Dulaglutide is a once-weekly GLP-1 receptor agonist consisting of two identical chains, each containing a GLP-1 analog covalently linked to a human IgG4-Fc heavy chain. This structure extends its half-life to about one week. FDA-approved for type 2 diabetes with proven cardiovascular benefits.
Research Notes
REWIND trial demonstrated cardiovascular benefits. Well-established safety profile with years of clinical use. User-friendly single-dose pen device.
Potential Side Effects
- •Nausea
- •Diarrhea
- •Abdominal pain
- •Decreased appetite
- •Vomiting
- •Fatigue
Always consult with a healthcare professional before starting any peptide therapy.